Bexion Pharmaceuticals

Bexion Pharmaceuticals is a company committed to the discovery, clinical development, and acquisition of oncology treatments. Its solution targets unique features of cancer cells, including externalized phosphatidylserine and tumor cell lysosomes by utilizing a small lysosomal protein known as Saposin C.